Experience With IVDR Implementation in Three Diagnostic Laboratories: Messages to EU Health Institutions, Diagnostic Healthcare Payers, and Authorities
Bart R. Lubbers,
Isabel Dombrink,
Tomas Kalina,
Mattias Hofmans,
Morten S. Bruun,
Simon J. Stanworth,
Marie C. Béné,
Konstanze Döhner,
Monika Brüggemann,
Elizabeth Macintyre,
Jacques J.M. van Dongen
Affiliations
Bart R. Lubbers
1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands
Isabel Dombrink
1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands
Tomas Kalina
4 CLIP, Department of Paediatric Haematology/Oncology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic
Mattias Hofmans
5 Department of Laboratory Medicine, Ghent University Hospital, Belgium
Morten S. Bruun
6 Danish Medicines Agency, Copenhagen, Denmark
Simon J. Stanworth
1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands
Marie C. Béné
1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands
Konstanze Döhner
1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands
Monika Brüggemann
1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands
Elizabeth Macintyre
1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands
Jacques J.M. van Dongen
1 EHA Taskforce on IVD, European Hematology Association, The Hague, The Netherlands
